SCHEMBL9515974

SCHEMBL9515974

O=C(NS(=O)(=O)CCCC(O)c1ccc(C(F)(F)F)cc1)c1ccc(CO)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39
HDAC3 O15379 3/20 0.36
HDAC1 Q13547 3/20 0.36
HDAC2 Q92769 3/20 0.36
HDAC6 Q9UBN7 3/20 0.36
HSD11B1 P28845 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
PPARD Q03181 4/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MCHR1 Q99705 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC10 Q969S8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516279 0.95 HIF1A (0.39) HIF1AEPAS1HDAC3HDAC1HDAC2
SCHEMBL9518016 0.89 MEN1 (0.38) HDAC3HDAC1HDAC2HDAC6MEN1
SCHEMBL9515773 0.89 HSD11B1 (0.43) HIF1AEPAS1HDAC3HDAC1HDAC2
SCHEMBL9515431 0.89 PNMT (0.41) HDAC3HDAC1HDAC2HDAC6CES2
SCHEMBL9515897 0.87 EGFR (0.42) HDAC3HDAC1HDAC2HDAC6PPARD
SCHEMBL9519439 0.83 PNMT (0.42) HDAC3HDAC1HDAC2HDAC6CES2
SCHEMBL9515637 0.83 EPHX2 (0.38) HDAC3HDAC1HDAC2HDAC6MEN1
SCHEMBL9519314 0.82 EGFR (0.37) HDAC6MEN1NPC1RAB9AKMT2A
SCHEMBL9516131 0.82 GABRA5 (0.40)
SCHEMBL9519674 0.81 EGFR (0.43) HDAC3HDAC1HDAC2HDAC6PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed